Autolus Therapeutics Ltd reported $493.23M in Assets for its fiscal quarter ending in June of 2026.





Assets Change Date
AstraZeneca USD 119.92B 4.09B Sep/2026
Autolus Therapeutics Ltd USD 493.23M 33.84M Jun/2026
Hikma Pharmaceutical USD 5.67B 117M Dec/2025
Novartis USD 117.15B 4.88B Sep/2026
Roche Holding CHF 98.2B 2.5B Jun/2026
Silence Therapeutics USD 131.44M 15.35M Dec/2025